Exact Mass: 490.3172
Exact Mass Matches: 490.3172
Found 91 metabolites which its exact mass value is equals to given mass value 490.3172
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Arachidonoyl Tryptophan
N-arachidonoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Sapacitabine
(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol
Phe Ile Ile Val
Phe Ile Leu Val
Phe Ile Val Ile
Phe Ile Val Leu
Phe Leu Ile Val
Phe Leu Leu Val
Phe Leu Val Ile
Phe Leu Val Leu
Phe Val Ile Ile
Phe Val Ile Leu
Phe Val Leu Ile
Phe Val Leu Leu
Ile Phe Ile Val
Ile Phe Leu Val
Ile Phe Val Ile
Ile Phe Val Leu
Ile Ile Phe Val
Ile Ile Val Phe
Ile Leu Phe Val
Ile Leu Val Phe
Ile Val Phe Ile
Ile Val Phe Leu
Ile Val Ile Phe
Ile Val Leu Phe
Leu Phe Ile Val
Leu Phe Leu Val
Leu Phe Val Ile
Leu Phe Val Leu
Leu Ile Phe Val
Leu Ile Val Phe
Leu Leu Phe Val
Leu Leu Val Phe
Leu Val Phe Ile
Leu Val Phe Leu
Leu Val Ile Phe
Leu Val Leu Phe
Val Phe Ile Ile
Val Phe Ile Leu
Val Phe Leu Ile
Val Phe Leu Leu
Val Ile Phe Ile
Val Ile Phe Leu
Val Ile Ile Phe
Val Ile Leu Phe
Val Leu Phe Ile
Val Leu Phe Leu
Val Leu Ile Phe
Val Leu Leu Phe
3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid
Sapacitabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000970 - Antineoplastic Agents Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.